Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA

Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).

Read the whole article on Physorg

More from Physorg